Compare Era Mandiri Cemerlang Tbk. (IKAN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Era Mandiri Cemerlang Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp87 (market cap 74.17B, 31.56M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 8.8× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (31.56M versus 848.2K). Which is the better fit depends on your goals.
| IKAN | LABS | |
|---|---|---|
Market Cap | 74.17B | 651.75B |
Volume | 31.56M | 848.2K |
Lot | 315.65K | 8.48K |
Turnover | 2.84B | 140.51M |
Average Price | 90.04 | 165.66 |
Value | 2.84B | 140.51M |
Indicative Equilibrium Price | 87 | 168 |
Indicative Equilibrium Volume | 3.42K | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Era Mandiri Cemerlang Tbk.
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
